Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Product Information Update- Targocid (teicoplanin) 200mg and 400mg Powder and Solvent for Solution for Injection/infusion or oral solution
Notice type:
3rd Party Publications
Date:
29/09/2014
Important Update to Indications, Dosage and Duration of Use
Product name or type:
Targocid (teicoplanin) 200mg and 400mg Powder and Solvent for Solution for Injection/infusion or oral solution
Authorisation Holder:
Sanofi
Further Information:
Product Information Update- Targocid (teicoplanin) 200mg and 400mg Powder and Solvent
« Back
Date Printed: 03/05/2024